Marie Ménard

1.4k total citations
11 papers, 266 citations indexed

About

Marie Ménard is a scholar working on Molecular Biology, Oncology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Marie Ménard has authored 11 papers receiving a total of 266 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Oncology and 2 papers in Cellular and Molecular Neuroscience. Recurrent topics in Marie Ménard's work include Cell death mechanisms and regulation (4 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Pancreatic and Hepatic Oncology Research (2 papers). Marie Ménard is often cited by papers focused on Cell death mechanisms and regulation (4 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Pancreatic and Hepatic Oncology Research (2 papers). Marie Ménard collaborates with scholars based in United States, France and Australia. Marie Ménard's co-authors include Sweta Iyer, Ruth M. Kluck, Grant Dewson, Thanh Ngoc Nguyen, Iris K. L. Tan, Michael T. Ryan, Robert L. Ninnis, Stephen Ma, David A. Stroud and Peter E. Czabotar and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and SHILAP Revista de lepidopterología.

In The Last Decade

Marie Ménard

10 papers receiving 263 citations

Peers

Countries citing papers authored by Marie Ménard

Since Specialization

Citations

This map shows the geographic impact of Marie Ménard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marie Ménard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marie Ménard more than expected).

Fields of papers citing papers by Marie Ménard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marie Ménard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marie Ménard. The network helps show where Marie Ménard may publish in the future.

Co-authorship network of co-authors of Marie Ménard

This figure shows the co-authorship network connecting the top 25 collaborators of Marie Ménard. A scholar is included among the top collaborators of Marie Ménard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marie Ménard. Marie Ménard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

#	Work	Indexed citations
1	Cancer interception with KRAS inhibitors in preclinical models of pancreatic ductal adenocarcinoma 2026 ·Science ·(unknown), (unknown), Rina Sor, (unknown), Nune Markosyan, Emma E. Furth, (unknown), (unknown), Marie Ménard, (unknown), (unknown), Connor J. Hennessey, (unknown), Liz Quinones, (unknown), Cynthia Clendenin, (unknown), (unknown), Ben Z. Stanger	0
2	Abstract PR012: The RAS(ON) G12D-selective inhibitor RMC-9805 synergizes with anti-PD-1 to extend durability of antitumor activity in KRAS G12D-driven preclinical cancer models 2025 ·Cancer Immunology Research ·Marie Ménard, (unknown), Lilit Grigoryan, Jasmine Lee, Cheng Liu, (unknown), (unknown), (unknown), Ximo Pechuan-Jorge, (unknown), (unknown), (unknown), (unknown), Lillian Seu, (unknown), Elsa Quintana	1
3	T-cell Dependency of Tumor Regressions and Complete Responses with RAS(ON) Multi-selective Inhibition in Preclinical Models of Pancreatic Ductal Adenocarcinoma 2025 ·Cancer Discovery ·(unknown), William P. Vostrejs, Rina Sor, (unknown), Samantha B. Kemp, Il‐Kyu Kim, Adam B. Kramer, Nataliya Tovbis Shifrin, Nune Markosyan, Cynthia Clendenin, Mallika Singh, Elsa Quintana, Marie Ménard, Robert H. Vonderheide, Ben Z. Stanger	9
4	Abstract ND03: Discovery of RMC-9805, an oral, covalent tri-complex KRASG12D(ON) inhibitor 2024 ·Cancer Research ·John E. Knox, G. Leslie Burnett, Caroline E. Weller, (unknown), Dongyu Zhang, (unknown), Abby Marquez, Kyle J. Seamon, (unknown), Marie Ménard, Elsa Quintana, Zhe Chen, Zhican Wang, Zhengping Wang, Elena S. Koltun, (unknown), Jingjing Jiang, David Wildes, Jacqueline A.M. Smith, Adrian L. Gill	12
5	214 The KRAS^G12D(ON) covalent tricomplex inhibitor RM-044 increases tumor antigen presentation and TCR repertoire diversity to promote anti-tumor immunity in a preclinical model of KRAS^G12D mutant cancer 2023 ·SHILAP Revista de lepidopterología ·Nataliya Tovbis Shifrin, Marie Ménard, (unknown), (unknown), (unknown), Lillian Seu, Jacqueline A.M. Smith, Elsa Quintana	2
6	Abstract 3475: RMC-9805, a first-in-class, mutant-selective, covalent and orally bioavailable KRASG12D(ON) inhibitor, promotes cancer-associated neoantigen recognition and synergizes with immunotherapy in preclinical models 2023 ·Cancer Research ·Marie Ménard, Christopher W.K. Chow, Kevin Chen, Cristina Blaj, Nataliya Tovbis Shifrin, (unknown), Nicole Nasholm, (unknown), (unknown), (unknown), James Evans, (unknown), (unknown), (unknown), Jingjing Jiang, John E. Knox, Jacqueline A.M. Smith, Elsa Quintana	17
7	The dependence receptor TrkC regulates the number of sensory neurons during DRG development 2018 ·Developmental Biology ·Marie Ménard, (unknown), Juliana M. Coelho‐Aguiar, Loraine Jarrosson-Wuillème, Nicolas Rama, (unknown), Karine Kindbeiter, Muriel Bozon, Jorge Rubén Cabrera, Élisabeth Dupin, Nicole Le Douarin, Patrick Mehlen, Servane Tauszig-Delamasure	4
8	Hey1- and p53-dependent TrkC proapoptotic activity controls neuroblastoma growth 2018 ·PLoS Biology ·Marie Ménard, (unknown), Gabriel Ichim, (unknown), David Neves, Loraine Jarrosson-Wuillème, Reinhard Depping, Jan Köster, Pierre Saintigny, Patrick Mehlen, Servane Tauszig-Delamasure	14
9	Bax targets mitochondria by distinct mechanisms before or during apoptotic cell death: a requirement for VDAC2 or Bak for efficient Bax apoptotic function 2014 ·Cell Death and Differentiation ·Stephen Ma, Thanh Ngoc Nguyen, Iris K. L. Tan, Robert L. Ninnis, Sweta Iyer, David A. Stroud, Marie Ménard, Ruth M. Kluck, Michael T. Ryan, Grant Dewson	101
10	Apoptotic pore formation is associated with in-plane insertion of Bak or Bax central helices into the mitochondrial outer membrane 2014 ·Proceedings of the National Academy of Sciences ·Dana Westphal, Grant Dewson, Marie Ménard, (unknown), Sweta Iyer, Ray C. Bartolo, Leonie Gibson, Peter E. Czabotar, Brian J. Smith, Jerry M. Adams, Ruth M. Kluck	91
11	The Dependence Receptor TrkC Triggers Mitochondria-Dependent Apoptosis upon Cobra-1 Recruitment 2013 ·Molecular Cell ·Gabriel Ichim, (unknown), Marie Ménard, Li-Ying Yu, Juliana M. Coelho‐Aguiar, Fabien Llambi, Loraine Jarrosson-Wuillème, J Lefèbvre, David Tulasne, Élisabeth Dupin, Nicole Le Douarin, Urmas Arumäe, Servane Tauszig-Delamasure, Patrick Mehlen	15

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact